ZNTL CIK: 1725160

Zentalis Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−154
FY22:
−164
FY23:
−208
FY24:
−171
FY25:
−125
Change from FY21 to FY25
millions USD
FY21:
−18.1
FY22:
−114
FY23:
−44.5
FY24:
177
FY25:
132
Change from FY21 to FY25
millions USD
FY21:
179
FY22:
261
FY23:
237
FY24:
0.11
FY25:
−4.28
millions USD
FY21:
6.31
FY22:
−16.9
FY23:
−15.0
FY24:
5.81
FY25:
2.09
(positive)
Change from FY21 to FY25
millions USD
FY21:
−160
FY22:
−166
FY23:
−208
FY24:
−171
FY25:
−125

All amounts in millions USD Data source:SEC EDGAR